You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
IGF::OT::IGF-- Biomarkers for Alcohol and ALD
SBC: ECHELON BIOSCIENCES, INC. Topic: NIAAAThis contract addresses the need for reliable and accurate biomarkers of alcohol consumption, initially in response to a National Institute on Alcohol Abuse and Alcoholism (NIAAA)-initiated Small Business Innovation Research (SBIR) contract topic on Biomarkers for Alcohol-induced Disorders. The goals of this contract are to advance the usefulness of phosphatidylethanol (PEth), an alcohol metabolit ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
HHSN261201400049C; TOPIC 309- DEVELOPMENT OF LOW COST, SMALL SAMPLE MULTI-ANALYTE TECHNOLOGIES FOR CANCER DIAGNOSIS, PROGNOSIS AND EARLY DETECTION; TITLE: LOW-VOLUME, ULTRA-SENSITIVE IMMUNODIAGNOSTIC
SBC: SILOAM BIOSCIENCES Topic: NCINot Available
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
IGF::OT::IGF SBIR Topic 66 Phase II: Haptoglobin Treatment to Reduce Complications of Sickle Cell Disease
SBC: NANOSHELL COMPANY, LLC Topic: NHLBINot Available
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Helium Free MRI Image Guided Radiation Therapy (IGRT) System for ViewRay Inc
SBC: HYPER TECH RESEARCH INC Topic: NCI? DESCRIPTION (provided by applicant): This NIH Bridge Grant will result in a conduction cooled, liquid helium free, MRI background magnet for a commercial image guided radiation treatment (IGRT) for cancer treatment. The program will ensure the successful continued commercialization of our customer's image guided radiation therapy (IGRT) system, a vital cancer treatment device now treati ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Miniature Stimulator for Temporary Therapies
SBC: SPR THERAPEUTICS, INC. Topic: NICHDDESCRIPTION (provided by applicant): The goal of this project is to collect the safety and effectiveness clinical data necessary to commercialize the SMARTPATCH(R) system for post-stroke shoulder pain (PSSP). The prevalence of stroke is approximately 8 million in the US, with 795,000 additional persons surviving a stroke each year. Moderate to severe shoulder pain develops in a quarter to a third ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Alternative Pathway Inhibitors for Orphan Indication
SBC: Novelmed Therapeutics Inc Topic: NHLBIDESCRIPTION (provided by applicant): Paroxysmal Nocturnal Hemoglobinuria (PNH) is an orphan disease characterized by severe anemia, kidney and liver failure, and ultimately death, if left untreated. In 2007, FDA approved the first complement inhibitor, Eculizumab (Soliris(R)), for the treatment of PNH. Eculizumab binds to C5 and prevents C5 cleavage and the formation of C5b-9, a complement product ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Epoch Telemetry System for Long-Term Monitoring of Biopotentials
SBC: EPITEL, INC. Topic: NINDSDESCRIPTION (provided by applicant): Epoch Telemetry System for Long-Term Monitoring of Biopotentials ABSTRACT Epoch is a wireless, multi- channel biopotential recording system designed for small animal translational research models of human disease developed in Phase I and II. Obtaining long- term continuous recordings from animal models of disease is a critical component of translational resear ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Health Effects of CREON2000 in Asthmatic Children
SBC: General Innovations and Goods, Inc. Topic: NIAIDDESCRIPTION (provided by applicant): The purpose of this trial is to investigate the effectiveness of the CREON2000A for improving asthma control and preventing or reducing asthma events in children with mild to moderate allergic asthma. The patented CREON2000A device is being developed as an environmental control intervention that will serve as an adjunctive treatment of asthma. The compact energ ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer
SBC: THERATARGET, INC. Topic: NCIDESCRIPTION provided by applicant The purpose of this Phase II STTR project is to develop a polymeric system for the combination delivery of two antineoplastic agents gemcitabine and paclitaxel Based on the successful results of the STTR Phase I award this Phase II proposal details the rationale and research plan for the synthesis and evaluation of in vivo efficacy of two novel macromolecula ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Miniature Stimulator for Temporary Therapies
SBC: SPR THERAPEUTICS, INC. Topic: NICHDDESCRIPTION provided by applicant The goal of this project is to collect the safety and effectiveness clinical data necessary to commercialize the SMARTPATCH R system for post stroke shoulder pain PSSP The prevalence of stroke is approximately million in the US with additional persons surviving a stroke each year Moderate to severe shoulder pain develops in a quarter to a third ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
